SBC Medical Group (SBC) Stock Insights

SBC price $5.45 +0.24 +4.61%

Ticker
SBC
Price
$5.45
Change
+0.24 +4.61%
Market cap ?
$560.52M
Beta ?
0.63
Sector
Industrials
Industry
Consulting Services

Fair value

SBC fair value $10.02. Price $5.45. Price is 46% below fair value.

Below fair value, around its usual discount.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 74.96M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 102.85M. Net debt -112.14M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare SBC

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-13—0.11—48.90M
2026-08-130.100.1249.19M45.37M
2026-05-140.110.1043.06M41.66M
2026-03-270.140.1339.57M45.44M
2025-11-140.120.1343.35M45.19M
2025-08-130.020.1443.36M45.65M
2025-05-150.210.1147.33M44.71M
2025-03-280.060.1744.00M56.85M
2024-11-130.030.1953.08M56.34M
2024-08-160.20—53.00M—
2024-06-170.20—54.81M—
2023-12-310.10—193.54M—
2023-09-300.08—47.28M—
2023-06-301.34—41.00M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-04-28Aikawa YoshiyukiSell465.00K$3.021.41M
2026-04-21Aikawa YoshiyukiSell3.10M$3.029.37M
2026-03-06Aikawa YoshiyukiSell4.42M$2.129.38M
2026-03-06Aikawa YoshiyukiSell44.23K$2.1293.77K
2026-03-06Aikawa YoshiyukiBuy44.23K$2.1293.77K
2025-04-10Yamazaki MikiOther0——
2024-09-30SAYAMA MIKE KBuy15.00K——
2024-09-19ZUU Co. Ltd.Buy6.20K$7.3445.48K
2024-09-17Aikawa YoshiyukiOther0——
2024-09-17ZUU Co. Ltd.Buy1.50M——
2024-09-17ZUU Co. Ltd.Buy1$0.010
2024-09-17Aikawa YoshiyukiSell1.50M——
2024-09-17SAYAMA MIKE KOther0——
2024-09-17Edahiro KenOther0——
2024-09-17Fujiwara FumitoshiOther0——
2024-09-17Komatsu AkiraOther0——
2024-09-17Murata RyojiOther0——
2024-09-17Yoshida YuyaOther0——
2024-09-17Aikawa YoshiyukiSell0——

Institutional holders

HolderSharesChangeChange %Value
No data yet.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

SBC Medical Group (SBC) Stock Insights

SBC$5.45+0.24 +4.61%

$560.52M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History